Gene Suppression for Effective Glioblastoma Treatment

Suppressing the OSMR gene can improve the effectiveness of radiation therapy in glioblastoma, a type of brain cancer. This gene controls energy production in the cancer stem cells. Suppressing the gene reduces the energy production in the glioblastoma tumor cells and starves them to death.

The McGill-led study is published in Nature Communication

Cancer Immunotherapy
Cancer immunotherapy is a new advancement in cancer treatment that uses certain components of a person's immune system to fight against cancer cells.

‘Suppressing the OSMR gene activity leads to starving and death of the glioblastoma tumor cells. Therefore, targeting OSMR gene, in combination with radiation therapy, can be an effective method to treat glioblastoma tumours.’
Read More..

Tweet it Now

This approach, led by the laboratory of Arezu Jahani-Asl, Assistant Professor of Medicine at McGill University, was successful in preclinical mouse models where the deletion of the OSMR gene resulted in a significant improvement of tumour response to therapy and expanded lifespan.

Glioblastoma is the most common and aggressive cancerous brain tumour in adults due to its resistance to therapy. Treatment usually involves surgery, followed by chemotherapy and radiation therapy. Despite these intensive efforts, in most cases tumour cells regrow after treatment and the cancer recurs.

Starving cancer stem cells

Brain Metastasis - Causes, Symptoms, Diagnosis and Treatment
Brain metastases are caused by the spread of primary tumors to the brain. Lung, breast, melanoma are the three main tumors that cause brain metastases.

Glioblastoma tumours contain rare cancer stem cells responsible for therapeutic resistance and tumour regrowth. In the study, researchers uncover the unique role OSMR plays in fortifying cancer stem cells’ resistance to therapy by strengthening mitochondria, the powerhouse of cell energy production. It makes the long journey to the mitochondria and interacts with energy-producing machinery to force them to generate more energy for cancer cells.

"To improve patient response to glioblastoma treatment, we must find new vulnerabilities in cancer stem cells and overcome their resistance to therapy. By suppressing OSMR, we were able to halt energy production in cancer stem cells, essentially starving them to death," says Jahani-Asl.

Novel Targeted Therapy Against Glioblastoma
Researchers at the Spanish National Cancer Research Centre used mouse models to suppress glioblastoma tumor growth by blocking TRF1 telomere protein.

The study provides evidence that targeting OSMR gene, in combination with radiation therapy, can pave the way for future clinical trials that better treat glioblastoma tumours. The next step is to leverage these tools into a clinical trial, the researchers say.

Source-Eurekalert

New Breast Cancer Drug may Treat Glioblastoma
New clinical trial identifies ribociclib drug as a potential treatment for recurrent glioblastoma.